KFDA to prop up DMF system

Published: 2003-07-25 07:00:00

Updated: 2003-07-25 07:00:00

The Korea Food and Drug Administration disclosed a plan to incrementally expand the coverage of Drug Master File (DMF) system to bioequivalence-tested items in addition to new drugs, which was introduced in July of last year as part of its efforts to perform more systematic management of finished...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK